AbbVie (BSP:ABBV34) Accounts Payable & Accrued Expense : R$155,997 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is AbbVie Accounts Payable & Accrued Expense?

AbbVie's quarterly accounts payable & accrued expense increased from Sep. 2023 (R$146,472 Mil) to Dec. 2023 (R$150,179 Mil) and increased from Dec. 2023 (R$150,179 Mil) to Mar. 2024 (R$155,997 Mil).

AbbVie's annual accounts payable & accrued expense increased from Dec. 2021 (R$128,361 Mil) to Dec. 2022 (R$133,244 Mil) and increased from Dec. 2022 (R$133,244 Mil) to Dec. 2023 (R$150,179 Mil).

AbbVie Accounts Payable & Accrued Expense Historical Data

The historical data trend for AbbVie's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Accounts Payable & Accrued Expense Chart

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

48,564.44

103,712.01

128,360.58

133,243.65

150,178.87

AbbVie Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															129,115.99	131,224.63	146,471.97	150,178.87	155,997.22

AbbVie Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

AbbVie (BSP:ABBV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV:Austria

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (BSP:ABBV34) Headlines

No Headlines